ETF · Invesco
WHCG Invesco S&P World Health Care ESG UCITS ETF Accum USD
ISIN IE000L4EH2K5London Stock Exchange: WHCGInvesco Ltd.
- Healthcare
- ETF
- ISA
- SIPP
- Accumulating
Latest close
LSE£5.64
on
- Ongoing charge
- 0.18% a year
- Fund size
- £15.4m
As of , at least 15 min delayed
At a glance
As of 20/11/2026, WHCG (Invesco S&P World Health Care ESG UCITS ETF Accum USD, ISIN IE000L4EH2K5) closed at £5.64 on the London Stock Exchange. Its ongoing charge is 0.18% a year (about £18 on £10,000). Over the three years to 20/11/2026 its total return was +23.8%, or +11.5% after UK CPIH inflation.
Past returns
- 1 year to 20/11/2026
- +14.6%
- +10.6% after inflation (UK CPIH)
- 3 years to 20/11/2026
- +23.8%
- +11.5% after inflation (UK CPIH)
Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Calendar-year and 12-month returns
Calendar-year returns of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund): 2024 +4.9%, 2025 +5.6%; 2026 to 19/11/2026 +15.5%. Returns of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +13.6%; to 30/09/2025: −4.7%; to 30/09/2024: +11.5%.
| Year | Return | After inflation | Return shown as a bar |
|---|---|---|---|
| to | +15.5% | +11.4% | |
| to | +5.6% | +1.9% | |
| to | +4.9% | +1.3% |
| 12 months to | Return | After inflation |
|---|---|---|
| from | +13.6% | +9.6% |
| from | −4.7% | −8.5% |
| from | +11.5% | +8.7% |
As of , inflation: UK CPIH
How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing
Risk: volatility and largest fall
Volatility (annualised)
15.5%over 3 years
| 1 year | 18.1% |
|---|---|
| 3 years | 15.5% |
Annualised from weekly returns. Higher means bumpier.
- Largest fall since April 2023
- −20.0%
- From to
- Lowest 12-month return
- −17.1%
- 12 months to
- Highest 12-month return
- +24.9%
- 12 months to
- Below its highest weekly close since April 2023
- 3.7%
- High of , latest
In words: Volatility of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds, annualised from weekly returns to 19/11/2026: 18.1% over 1 year, 15.5% over 3 years. Largest fall in the price of Invesco S&P World Health Care ESG UCITS ETF Accum USD since April 2023, in pounds: −20.0% from 30/08/2024 to 23/05/2025. The lowest 12-month return of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) since April 2023 was −17.1% (12 months to 08/08/2025); the highest was +24.9% (12 months to 30/10/2026). On 19/11/2026 the price of Invesco S&P World Health Care ESG UCITS ETF Accum USD was 3.7% below its highest weekly close since April 2023 (13/11/2026), in pounds.
As of , price, with income reinvested in the fund
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.18%
- a year
- On £10,000
- £18
- a year, roughly
- Over five years
- £90
- of £10,000, before growth
- 4 charge less
- 3 the same
- 21 charge more
Ongoing charge of Invesco S&P World Health Care ESG UCITS ETF Accum USD 0.18% a year. Compared on 20/11/2026, 21 of the 28 other healthcare funds charge more, 3 the same and 4 less (share classes counted once).
As of
A lower charge is not a promise of a higher return: what the fund holds matters more.
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
Invesco S&P World Health Care ESG UCITS ETF Accum USD is an exchange-traded fund (ETF) from Invesco, launched in 2023.
It tracks the S&P World ESG Enhanced Health Care Index.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.18% a year — about £18 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN
Key facts
- Ticker
- WHCG
- ISIN
- IE000L4EH2K5
- Also listed as
- WHCE (London Stock Exchange, US dollars), WH2E (Xetra, euros)
- Provider
- Invesco
- Tracks
- S&P World ESG Enhanced Health Care Index
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Accumulating
- Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
- Ongoing charge
- 0.18% a year · about £18 on £10,000
- Fund size
- £15.4m
- Launched
- Domicile
- Ireland
- UK reporting fund status
- Yes — on HMRC’s list of reporting funds (list of )
- Reporting fund since . What reporting fund status means
- Can usually be held in
- ISA and SIPP
- Check with your platform: each decides which funds it offers.
- Currency hedged
- No
- Price currency
- Pounds (GBP)
- Category
- Healthcare
Price chart
Over the last year, the closing price went from £4.90 on 21/11/2025 to £5.64 on 20/11/2026 (+15.3%). The lowest close shown was £4.41 on 08/05/2026 and the highest £5.83 on 13/11/2026.
One close a week. Before 02/10/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded.
As of , at least 15 min delayed
Five years of prices, and after inflation
188 weekly closes, from 21/04/2023 to 20/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
What it holds
- Holdings
- 66
- on record
- Ten largest
- 65.1%
- of the whole fund
- Effective number of holdings
- 15
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 18.0%
- Eli Lilly
Top 10 holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | Eli LillyLLY | 17.96% |
| 2 | AbbVieABBV | 10.74% |
| 3 | MerckMRK | 6.12% |
| 4 | AstraZenecaAZN | 5.09% |
| 5 | Gilead SciencesGILD | 4.66% |
| 6 | RocheRO | 4.48% |
| 7 | NovartisNOVN | 4.37% |
| 8 | AmgenAMGN | 4.23% |
| 9 | Thermo Fisher ScientificTMO | 4.20% |
| 10 | Abbott LaboratoriesABT | 3.27% |
As of , holdings as published
Where it invests
The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.
By country
- United States68.8%
- Switzerland10.2%
- United Kingdom5.9%
- Japan4.2%
- Ireland2.3%
- France2.1%
- Denmark1.4%
- Australia1.2%
- Other countries3.8%
See the full portfolio
Every holding with search and filters, the whole breakdown by sector, country and type of asset, a map of the 66 largest and what changed since .
All holdings
The fund publishes 66 holdings; the ten largest make up 65.1% of it.
Create a free account to see the full holdings list
Sign-up takes an email address. There is no card to enter and nothing to pay.
Sector split
As a share of the whole fund. 99.6% of it is classified by sector; bonds, cash and positions that cannot be matched are left out rather than guessed.
- Health Technology94.8%
- Health Services4.2%
- Commercial Services0.3%
- Retail Trade0.2%
Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1 and 3 years, from weekly returns in pounds.
With a free accountRolling returns
The full range of 136 rolling 12-month returns since April 2023, in pounds, with how often they were above zero.
With a free accountLargest falls and recoveries
The 3 largest falls since April 2023, in pounds, with how many weeks each took to reach its low and to recover.
With a free account
Create a free account to see the risk ratios, every rolling return and each large fall and its recovery
Sign-up takes an email address. There is no card to enter and nothing to pay.
Rank among similar funds
Rank by total return over 1 and 3 years among up to 11 healthcare funds investing globally, not currency-hedged, highest first.
ProMoves compared with a similar fund
Correlation and beta of weekly returns in pounds against iShares Core MSCI World UCITS ETF, over the three years to 19/11/2026 (154 weeks).
Pro
Pro — currently by invitation
Pro includes the rank among similar funds and moves against a comparable fund
Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].
Questions people ask
What is the ongoing charge of WHCG?
The ongoing charge of WHCG is 0.18% a year — about £18 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco S&P World Health Care ESG UCITS ETF Accum USD 0.18% a year. Compared on 20/11/2026, 21 of the 28 other healthcare funds charge more, 3 the same and 4 less (share classes counted once).
What does WHCG track?
WHCG tracks the S&P World ESG Enhanced Health Care Index.
Is WHCG accumulating or distributing?
WHCG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
What is the ISIN of WHCG?
The ISIN of WHCG is IE000L4EH2K5. An ISIN identifies one exact share class of a fund; WHCG is its ticker on the London Stock Exchange. The same share class is also listed as WHCE (London Stock Exchange, US dollars) and WH2E (Xetra, euros).
What does WHCG hold?
As of 12/11/2026, WHCG holds 66 positions, according to its published holdings. The largest is Eli Lilly at 17.96% of the fund; the ten largest make up 65.1%. Its ten largest holdings are Eli Lilly (17.96%), AbbVie (10.74%), Merck (6.12%), AstraZeneca (5.09%), Gilead Sciences (4.66%), Roche (4.48%), Novartis (4.37%), Amgen (4.23%), Thermo Fisher Scientific (4.20%) and Abbott Laboratories (3.27%).
What were WHCG’s returns in each of the last five years?
Calendar-year returns of WHCG in pounds (price, with income reinvested in the fund): 2024 +4.9%, 2025 +5.6%; 2026 to 19/11/2026 +15.5%. Past performance is not a guide to future returns.
How has WHCG done after inflation?
Over the three years to 20/11/2026 WHCG’s total return was +23.8%, or +11.5% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £3.4bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £2.7bn
- DRDRiShares Healthcare Innovation UCITS ETF0.40% a year · £1.2bn
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £1.2bn
- BTEKiShares NASDAQ US Biotechnology UCITS ETF0.35% a year · £994m
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £847m
- ESIHiShares MSCI Europe Health Care Sector UCITS ETF Accum EUR0.18% a year · £792m
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £779m
Fund documents and methods
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.